Delivery Order SPE2DB22D3019-SPE2DB25FK3GJ
Award Date
3/13/25
Potential Completion Date
3/14/25
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award is for the delivery of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,613.31, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 25, 2024. The contract is a delivery order with a firm fixed price. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the delivery of Fluticasone-Salmeterol 115-21 12GM medical products to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $3,118.10, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This federal contract award is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,981.33 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024, with a completion date of December 10, 2024. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp maintains a $999,999,999 Indefinite...
This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,940.81, is a Firm Fixed Price Delivery Order for the supply of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of July 5, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract was not designated with...
The federal contract award is for the delivery of Fluticasone-Salmeterol 230-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $4,447.61 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 13, 2025, with a completion date of March 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award is for the delivery of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,061.44 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,237.14 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 19, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,713.56, is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, and has an ultimate completion date of October 30, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,731.36, is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of November 1, 2024. The contract does not have a set-aside designation, indicating it was competed openly....
This contract award is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $1,210.73, was awarded on July 12, 2024 to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract has a firm fixed-price pricing type and an ultimate completion date of July 15, 2024....